Please login to the form below
Avonex
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.
Elan hit by 'disaster' withdrawal
Both patients were involved in a trial that examined the effectiveness of Tysabri in combination with Biogen's existing MS drug, Avonex, on the market for nearly nine years.
Analysts back Tysabri return despite FDA concern
Tysabri was withdrawn a year ago after two patients taking it in combination with another Biogen MS drug, Avonex, developed a rare and often fatal brain infection known as progressive multifocal
Lectus wins USD 6.1m investment from Wellcome Trust
It is the fifth largest segment of the CNS market. The MS market is currently dominated by six treatments: Avonex (Biogen), Betaseron/Betaferon (Schering), Copaxone (Teva), Novatrone (Schering), Rebif (Serono/ Pfizer)
New accounts: May
Grandma Vines. Dermatology (consumer). hsdcommunications. Biogen Idec. Avonex. CNS. TVF Communications.
PM Society Award Winners 2006
Craft Award:Detailing Aid. Winner:Seven Stones for Avonex. Sponsor: Ashfield Healthcare. Craft Award:GP Direct Mail Campaign. ... Sponsor:Wiley Pharmafile. Craft Award:Hospital Campaign. Winner:Seven Stones for Avonex. Sponsor: TNS Healthcare.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- Sinovac reveals positive preliminary data for COVID-19 vaccine
- Britain closes in on £500m COVID-19 vaccine deal with Sanofi/GSK
- FDA approves Roche’s Actemra COVID-19 trial
- The best work in healthcare communications shines at virtual Communiqué Awards
- Mesoblast expands compassionate use COVID-19 programme
- EU gives AZ’s Lynparza green light for BRCA-mutated pancreatic cancer
- The best work in healthcare communications shines at virtual Communiqué Awards
- Mearns & Pike, Electric Putty and Evoke KYNE make a clean sweep at Communiqué 2020
- Novavax gets $1.6bn from US government for coronavirus vaccine
- Biogen completes filing for highly-anticipated Alzheimer’s drug
- France’s Osivax raises over €30m for universal flu and coronavirus vaccines
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Multichannel engagement and the need for greater understanding of European markets
- By Laurence Olding and Georgina James...
- A snapshot of… Exscientia
- ...
- Patients are ready for virtual clinical trials, are you?
- Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...
Quick links
Infographics
